Oncos Therapeutics nominated again among the most promising startup companies
HELSINKI, Finland-Oncos Therapeutics Ltd., a company developing novel cancer immune therapeutics, was nominated among the 20 most promising startup companies in Finland for the second consecutive year. The nomination was made by Talouselämä, the leading Finnish business and economy magazine. "Finland is a country whose startup hype has traditionally dwelt around game-changing Angry Birdses and global ICT stars. It's quite an achievement to break a biotech company through to top 20 in such a country - and it's unheard of to make it twice in a row", comments Frans Wuite, CEO and President